Anxiety Disorder News and Research

RSS

Adolescents with higher levels of omega-3 fatty acids less likely to develop psychotic disorder

New research has found that adolescents with higher levels of an omega-3 fatty acid in their blood were less likely to develop psychotic disorder in early adulthood, suggesting that it may have a potential preventative effect of reducing the risk of psychosis.

1 Jun 2021

Smart device-based electronic platform can continuously monitor mental health

To help patients manage their mental wellness between appointments, researchers at Texas A&M University have developed a smart device-based electronic platform that can continuously monitor the state of hyperarousal, one of the signs of psychiatric distress.

27 May 2021

Experts debate on the true incidence and overdiagnosis of PTSD

Some clinicians are concerned that post-traumatic stress disorder (PTSD) diagnosis has risen throughout Western society since the late 1980s. Is this correct? And if so, has the true incidence of PTSD really spiralled out of control, or has it simply become overdiagnosed?

6 May 2021

Study observes neurological and psychiatric outcomes in recovered COVID-19 patients six months post-infection

A new study by researchers at Oxford University examines neurological and psychiatric outcomes in recovered COVID-19 patients six months post-infection.

15 Apr 2021

Impact of COVID-19 on mental health in the US: CDC report

The study, published in CDC's Morbidity and Mortality Weekly Report (MMWR), underlies the importance of evaluating the impact of strategies addressing adult mental health status during the pandemic. This way, these can help plan strategies and interventions for the affected groups.

30 Mar 2021

High levels of progesterone can reduce stress after concussion, speed recovery in females

Could birth control pills help young female athletes recover faster from concussions and reduce their symptoms?

16 Mar 2021

Computerized, remote training program alleviates negative emotions in preadolescents

Anxiety levels in the United States are rising sharply and have especially intensified in younger populations.

9 Mar 2021

FAIR Health study highlights the impact of COVID-19 on pediatric mental health

In March and April 2020, mental health claim lines for individuals aged 13-18, as a percentage of all medical claim lines, approximately doubled over the same months in the previous year.

2 Mar 2021

B.1.1.7 variant and healthcare workers’ travel worry

Recently a team of researchers from Saudi Arabia, the United Arab Emirates, and the United States assessed travel-related anxiety in healthcare workers (HCWs) considering the emergence of new variants caused by SARS-CoV-2 mutations.

25 Jan 2021

Mental disorders highly prevalent during coronavirus pandemics

Researchers in the United States have conducted an analysis showing the high prevalence of mental disorders across populations impacted by coronavirus pandemics.

24 Dec 2020

How has the COVID-19 pandemic affected the wellbeing of healthcare workers?

A new study by US-based researchers – at the Northwest Mental Illness Research, Education and Clinical Center and Columbia University – has found that healthcare workers have experienced significant psychiatric distress during the pandemic.

21 Dec 2020

Researchers develop survey to understand factors that influence vaping

Before the COVID-19 pandemic, information about the dangers of vaping was emerging. To investigate the potentially serious health and respiratory implications of vaping, Mayo Clinic researchers wanted to better understand the factors influencing vaping in the community.

23 Nov 2020

Antidepressant drug fluvoxamine may prevent some serious complications of COVID-19

In a preliminary study of COVID-19 patients with mild-to-moderate disease who were attempting to recover in their homes, researchers at Washington University School of Medicine in St. Louis have found that the drug fluvoxamine seems to prevent some of the most serious complications of the illness and make hospitalization and the need for supplemental oxygen less likely.

12 Nov 2020

Nearly 1 in 5 COVID-19 survivors develop mental illness within 90 days

A new study has found that people who have COVID-19 may have an increased risk of being diagnosed with a psychiatric disorder, including anxiety and depression, within 90 days after diagnosis.

10 Nov 2020

Study reveals major deficits in addressing asylum seekers’ mental health needs

A new study of asylum seekers in Germany suggests that, among those with symptoms of depression, anxiety, or posttraumatic stress disorder (PTSD), few receive a diagnosis from the health care system, and of those diagnosed, many do not receive treatment.

7 Oct 2020

Weighted blanket intervention reduces insomnia severity

Weighted blankets are a safe and effective intervention in the treatment of insomnia, according to Swedish researchers who found that insomnia patients with psychiatric disorders experienced reduced insomnia severity, improved sleep and less daytime sleepiness when sleeping with a weighted chain blanket.

23 Sep 2020

FDA announces requirement of class-wide labeling changes for benzodiazepines

The U.S. Food and Drug Administration announced today in a Drug Safety Communication that it is requiring an update to the Boxed Warning, the agency's most prominent safety warning, and requiring class-wide labeling changes for benzodiazepines to include the risks of abuse, misuse, addiction, physical dependence and withdrawal reactions to help improve their safe use.

23 Sep 2020